DS in Pharmatics

MAY 23, 2024

Could you please introduce yourself and your expertise in the pharmaceutical industry? I earned a Bachelor of Science in Chemistry at Fairfield University in 1979 and a Ph.D. in Organic Chemistry at Yale University in 1984 […] James Mencel’s Guidanceabout Scaling Up API Processes.

Organic Chemistry 52

Organic Chemistry Pharmaceuticals Science 52

Drug Target Review

DECEMBER 22, 2023

My secondary school chemistry teacher had a PhD in organic chemistry, and I found her classes and lab experiments to be very interesting, especially those in physical and organic chemistry. Excipients, or inactive ingredients in a drug formulation, are critical components.

Organic Chemistry 105

Organic Chemistry Science Pharmaceuticals Pharmacy 105

FDA Law Blog: Biosimilars

AUGUST 8, 2023

Lewis, Senior Regulatory Device & Biologics Expert — Please sing to the tune of “ Honesty ,” by Billy Joel: Nitrosamines, it’s such an ugly word, In pharmaceuticals’ impurity. Nitrosamines are hardly ever good, Now FDA has issued policy.

FDA 74

FDA Organic Chemistry Drugs Production 74

Drug Target Review

JULY 4, 2023

Author bios: Dr Petra Dieterich Petra has 30 years’ experience of drug development in the Pharmaceutical industry with a focus on supporting CMC activities. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

Drug Target Review

MARCH 15, 2024

How important is it to have role models for young women working in the pharmaceutical industry? About the author Dr Petra Dieterich, Senior Vice President at Abzena Petra has 30 years experience of in drug development in the pharmaceutical industry with a focus on supporting CMC activities.

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

The Pharma Data

OCTOBER 23, 2020

Elmaleh is a biotechnology entrepreneur, pharmaceutical chemist and molecular imaging expert with more than four decades of innovation in healthcare research. and Pure Tech Health. and Pure Tech Health. He also remains active as the chief executive officer and chairperson of AZTherapies Inc. Possessed of an inventive spirit, Dr.

Organic Chemistry 52

Organic Chemistry Clinical Trials Science Pharmaceuticals 52

The Pharma Data

NOVEMBER 11, 2020

He continued his education at Indiana University, where he completed a Master of Arts in botany in 1964, and a Doctor of Philosophy in organic chemistry in 1965. departing in 2003 to become the chief scientific officer for Tapestry Pharmaceuticals and ChromaDex Inc. In 2009, he established Ironstone Separations Inc.,

Organic Chemistry 52

Organic Chemistry Science Pharmaceuticals Pharmacy 52